Surface chemistry of perovskite nanoplatelets exhibiting circularly polarized luminescence

03 February 2022, Version 1
This content is a preprint and has not undergone peer review at the time of posting.


Chiral halide perovskite nanocrystals have many applications in next-generation optoelectronic devices due to their interaction with circularly polarized light. Through the careful selection of chiral organic surface ligands, control over the circular dichroism (CD) and circularly polarized luminescence (CPL) of these materials can be achieved. However, while recent developments of CD-active perovskites have seen significant advances, effective CPL remains a challenge. Here, we synthesize colloidal perovskite nanoplatelets exhibiting room temperature CPL with dissymmetry factors up to glum=4.3×10^(-3) and gabs=8.4×10^(-3). Methylammonium lead bromide nanoplatelets are synthesized with a mixture of chiral dimethyl benzyl ammonium ligands and achiral octylammonium ligands, the precise ratio of which is shown to be critical to achieving high g-factors. We investigate the competitive binding of these surface ligands using 1H NMR, and use an equilibrium model to demonstrate the ligand affinity. The magnitude of CPL and CD is quantitatively shown to exhibit a linear correlation, such that glum=0.4×gabs. Lastly, by screening several amines with close structures, we show that subtle differences in ligand structure have significant impact on the resulting CD signal of the nanoplatelets. Our findings provide new insights for the effective design of perovskites exhibiting CPL and can facilitate the development of high-performance devices based on circularly polarized luminescence.


ligand-induced chirality
circularly polarized luminescence
colloidal nanocrystals
chiral perovskites
surface chemistry

Supplementary materials

Supporting Information
Supporting Information including additional data containing TEM images, CD spectra of achiral NPLs and ligand salts, PXRD pattern of stacked NPLs, and optical characterization for NPLs synthesized with different chiral ligand fractions.


Comments are not moderated before they are posted, but they can be removed by the site moderators if they are found to be in contravention of our Commenting Policy [opens in a new tab] - please read this policy before you post. Comments should be used for scholarly discussion of the content in question. You can find more information about how to use the commenting feature here [opens in a new tab] .
This site is protected by reCAPTCHA and the Google Privacy Policy [opens in a new tab] and Terms of Service [opens in a new tab] apply.